Tamir Biotechnology Receives $1,524,978 New Financing

  • Feed Type
  • Date
    5/20/2016
  • Company Name
    Tamir Biotechnology
  • Mailing Address
    12625 High Bluff Dr. San Diego, CA 92130 USA
  • Company Description
    TamirBio is a clinical stage antiviral therapeutics company engaged in the discovery and development of a new class of prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions.
  • Website
    http://www.tamirbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,524,978
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed